About this trial
The aim of the study is to describe the socio-demographic, clinical, psychological, and psychiatric characteristics of patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes in these parameters over time after surgery. Additionally, the study seeks to describe the levels of quality of life, dissociative experiences, prevalence of various psychiatric symptoms, irritability, depressive symptoms, anxiety symptoms, and stigma perception in patients with drug-resistant focal epilepsy eligible for epilepsy surgery and any changes over time after surgery.
Eligibility criteria
Qualifiers
Patients aged 18 or older at the time of enrollment;
Patients with drug-resistant focal epilepsy followed at the Institute for at least 6 months;
Patients with drug-resistant focal epilepsy eligible for epilepsy surgery;
Patients capable of providing informed consent to participate in the study and for the processing of personal data.
Disqualifiers
Patients with evident and/or diagnosed cognitive or psychiatric disorders that prevent participation in an interview, proper understanding of informed consent, or completion of questionnaires.
Trial design
Treatments tested in this trial
- quality of life